ATTR AMYLOIDOSIS
Clinical trials for ATTR AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new ATTR AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for ATTR AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan aims to solve heart disease mystery
Diagnosis Recruiting nowThis study is testing a new type of PET scan to see if it can accurately diagnose a serious heart condition called cardiac AL amyloidosis. The test uses a special imaging dye to look for harmful protein buildup in the heart. Researchers will compare the scan results to current di…
Matched conditions: ATTR AMYLOIDOSIS
Phase: PHASE3 • Sponsor: Life Molecular Imaging GmbH • Aim: Diagnosis
Last updated Mar 23, 2026 15:17 UTC
-
Massive global study tracks rare disease patients for better understanding
Knowledge-focused Recruiting nowThis study aims to understand how ATTR amyloidosis affects people in real-world settings, not in controlled clinical trials. Researchers will follow 1,500 patients, including those with symptoms and those carrying the gene but without symptoms, to track disease progression and ho…
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Apr 01, 2026 20:11 UTC
-
Massive 52,000-Patient study maps the hidden journey of a rare heart and nerve disease
Knowledge-focused Recruiting nowThis study aims to understand the real-world experience of people with ATTR amyloidosis, a rare disease that affects the heart and nerves. Researchers will analyze existing health records of over 52,000 patients to learn about their symptoms, treatments, quality of life, and heal…
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC